# Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers

> **NCT02181959** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 138 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pharmaton® with DMAE
- **DRUG:** Pharmaton® without DMAE
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02181959
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-12
- **Primary completion:** 1999-04
- **Final completion:** —
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181959, "Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02181959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*